Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1992 Nov;76(11):681–684. doi: 10.1136/bjo.76.11.681

Pharmacokinetics of ophthalmic corticosteroids.

C N McGhee 1
PMCID: PMC504375  PMID: 1477046

Full text

PDF
681

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed I., Patton T. F. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci. 1985 Apr;26(4):584–587. [PubMed] [Google Scholar]
  2. BILL A. MOVEMENT OF ALBUMIN AND DEXTRAN THROUGH THE SCLERA. Arch Ophthalmol. 1965 Aug;74:248–252. doi: 10.1001/archopht.1965.00970040250024. [DOI] [PubMed] [Google Scholar]
  3. Ben-Nun J., Cooper R. L., Cringle S. J., Constable I. J. Ocular dialysis. A new technique for in vivo intraocular pharmacokinetic measurements. Arch Ophthalmol. 1988 Feb;106(2):254–259. doi: 10.1001/archopht.1988.01060130268041. [DOI] [PubMed] [Google Scholar]
  4. Bloomfield S. E., Miyata T., Dunn M. W., Bueser N., Stenzel K. H., Rubin A. L. Soluble gentamicin ophthalmic inserts as a drug delivery system. Arch Ophthalmol. 1978 May;96(5):885–887. doi: 10.1001/archopht.1978.03910050487020. [DOI] [PubMed] [Google Scholar]
  5. Burch P. G., Migeon C. J. Systemic absorption of topical steroids. Arch Ophthalmol. 1968 Feb;79(2):174–176. doi: 10.1001/archopht.1968.03850040176013. [DOI] [PubMed] [Google Scholar]
  6. Cox W. V., Kupferman A., Leibowitz H. M. Topically applied steroids in corneal disease. I. The role of inflammation in stromal absorption of dexamethasone. Arch Ophthalmol. 1972 Sep;88(3):308–313. doi: 10.1001/archopht.1972.01000030310017. [DOI] [PubMed] [Google Scholar]
  7. Doane M. G., Jensen A. D., Dohlman C. H. Penetration routes of topically applied eye medications. Am J Ophthalmol. 1978 Mar;85(3):383–386. doi: 10.1016/s0002-9394(14)77735-9. [DOI] [PubMed] [Google Scholar]
  8. Eilon L. A., Walker S. R. Clinical evaluation of clobetasone butyrate eye drops in the treatment of anterior uveitis and its effects on intraocular pressure. Br J Ophthalmol. 1981 Sep;65(9):644–647. doi: 10.1136/bjo.65.9.644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ellis P. P. Occlusion of the central retinal artery after retrobulbar corticosteroid injection. Am J Ophthalmol. 1978 Mar;85(3):352–356. doi: 10.1016/s0002-9394(14)77728-1. [DOI] [PubMed] [Google Scholar]
  10. Flint G. R., Morton D. J. Effect of derivatization of the bioavailability of ophthalmic steroids. Development of an in vitro method of evaluation. Arch Ophthalmol. 1984 Dec;102(12):1808–1809. doi: 10.1001/archopht.1984.01040031466024. [DOI] [PubMed] [Google Scholar]
  11. Friedberg M. L., Pleyer U., Mondino B. J. Device drug delivery to the eye. Collagen shields, iontophoresis, and pumps. Ophthalmology. 1991 May;98(5):725–732. doi: 10.1016/s0161-6420(91)32227-9. [DOI] [PubMed] [Google Scholar]
  12. Graham R. O., Peyman G. A. Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis. Arch Ophthalmol. 1974 Aug;92(2):149–154. doi: 10.1001/archopht.1974.01010010155016. [DOI] [PubMed] [Google Scholar]
  13. Green K., Downs S. J. Prednisolone phosphate penetration into and through the cornea. Invest Ophthalmol. 1974 Apr;13(4):316–319. [PubMed] [Google Scholar]
  14. Hakin K. N., Ham J., Lightman S. L. Use of orbital floor steroids in the management of patients with uniocular non-necrotising scleritis. Br J Ophthalmol. 1991 Jun;75(6):337–339. doi: 10.1136/bjo.75.6.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hill J. C., Maske R., Watson P. Corticosteroids in corneal graft rejection. Oral versus single pulse therapy. Ophthalmology. 1991 Mar;98(3):329–333. doi: 10.1016/s0161-6420(91)32291-7. [DOI] [PubMed] [Google Scholar]
  16. Hull D. S., Edelhauser H. F., Hyndiuk R. A. Ocular penetration of prednisolone and the hydrophilic contact lens. Arch Ophthalmol. 1974 Nov;92(5):413–416. doi: 10.1001/archopht.1974.01010010425011. [DOI] [PubMed] [Google Scholar]
  17. Hull D. S., Hine J. E., Edelhauser J. F., Hyndiuk R. A. Permeability of the isolated rabbit cornea to corticosteroids. Invest Ophthalmol. 1974 Jun;13(6):457–459. [PubMed] [Google Scholar]
  18. Hwang D. G., Stern W. H., Hwang P. H., MacGowan-Smith L. A. Collagen shield enhancement of topical dexamethasone penetration. Arch Ophthalmol. 1989 Sep;107(9):1375–1380. doi: 10.1001/archopht.1989.01070020445052. [DOI] [PubMed] [Google Scholar]
  19. Hyndiuk R. A. Radioactive depot-corticosteroid penetration into monkey ocular tissue. II. Subconjunctival administration. Arch Ophthalmol. 1969 Aug;82(2):259–263. doi: 10.1001/archopht.1969.00990020261021. [DOI] [PubMed] [Google Scholar]
  20. Hyndiuk R. A., Reagan M. G. Radioactive depot-corticosteroid penetration into monkey ocular tissue. I. Retrobulbar and systemic administration. Arch Ophthalmol. 1968 Oct;80(4):499–503. doi: 10.1001/archopht.1968.00980050501019. [DOI] [PubMed] [Google Scholar]
  21. Jennings T., Rusin M. M., Tessler H. H., Cunha-Vaz J. G. Posterior sub-Tenon's injections of corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol. 1988;32(4):385–391. [PubMed] [Google Scholar]
  22. Kalina R. E. Increased intraocular pressure following subconjunctival corticosteroid administration. Arch Ophthalmol. 1969 Jun;81(6):788–790. doi: 10.1001/archopht.1969.00990010790006. [DOI] [PubMed] [Google Scholar]
  23. Krupin T., Mandell A. I., Podos S. M., Becker B. Topical corticosteroid therapy and pituitary-adrenal function. Arch Ophthalmol. 1976 Jun;94(6):919–920. doi: 10.1001/archopht.1976.03910030459003. [DOI] [PubMed] [Google Scholar]
  24. Krupin T., Waltman S. R., Becker B. Ocular penetration in rabbits of topically applied dexamethasone. Arch Ophthalmol. 1974 Oct;92(4):312–314. doi: 10.1001/archopht.1974.01010010322012. [DOI] [PubMed] [Google Scholar]
  25. Kupferman A., Berrospi A. R., Leibowitz H. M. Fluorometholone acetate. A new ophthalmic derivative of fluorometholone. Arch Ophthalmol. 1982 Apr;100(4):640–641. doi: 10.1001/archopht.1982.01030030642023. [DOI] [PubMed] [Google Scholar]
  26. Kupferman A., Leibowitz H. M. Biological equivalence of ophthalmic prednisolone acetate suspensions. Am J Ophthalmol. 1976 Jul;82(1):109–113. doi: 10.1016/0002-9394(76)90674-7. [DOI] [PubMed] [Google Scholar]
  27. Kupferman A., Leibowitz H. M. Topically applied steroids in corneal disease. IV. The role of drug concentration in stromal absorption of prednisolone acetate. Arch Ophthalmol. 1974 May;91(5):377–380. doi: 10.1001/archopht.1974.03900060389009. [DOI] [PubMed] [Google Scholar]
  28. Kupferman A., Leibowitz H. M. Topically applied steroids in corneal disease. V. Dexamethasone alcohol. Arch Ophthalmol. 1974 Oct;92(4):329–330. doi: 10.1001/archopht.1974.01010010339016. [DOI] [PubMed] [Google Scholar]
  29. Kupferman A., Pratt M. V., Suckewer K., Leibowitz H. M. Topically applied steroids in corneal disease. 3. The role of drug derivative in stromal absorption of dexamethasone. Arch Ophthalmol. 1974 May;91(5):373–376. doi: 10.1001/archopht.1974.03900060385008. [DOI] [PubMed] [Google Scholar]
  30. Kupferman A., Ryan W. J., Jr, Leibowitz H. M. Prolongation of anti-inflammatory effect of prednisolone acetate. Influence of formulation in high-viscosity gel. Arch Ophthalmol. 1981 Nov;99(11):2028–2029. doi: 10.1001/archopht.1981.03930020904017. [DOI] [PubMed] [Google Scholar]
  31. LEOPOLD I. H., KROMAN H. S. Methyl- and fluoro-substituted prednisolones in the blood and aqueous humor of the rabbit. Concentrations. Arch Ophthalmol. 1960 Jun;63:943–947. doi: 10.1001/archopht.1960.00950020945008. [DOI] [PubMed] [Google Scholar]
  32. Lam T. T., Edward D. P., Zhu X. A., Tso M. O. Transscleral iontophoresis of dexamethasone. Arch Ophthalmol. 1989 Sep;107(9):1368–1371. doi: 10.1001/archopht.1989.01070020438050. [DOI] [PubMed] [Google Scholar]
  33. Leibowitz H. M., Kupferman A. Anti-inflammatory effectiveness in the cornea of topically administered prednisolone. Invest Ophthalmol. 1974 Oct;13(10):757–763. [PubMed] [Google Scholar]
  34. Leibowitz H. M., Kupferman A. Drug interaction in the eye. Concurrent corticosteroid-antibiotic therapy for inflammatory keratitis. Arch Ophthalmol. 1977 Apr;95(4):682–685. doi: 10.1001/archopht.1977.04450040148023. [DOI] [PubMed] [Google Scholar]
  35. Leibowitz H. M., Kupferman A. Kinetics of topically administered prednisolone acetate. Optimal concentration for treatment of inflammatory keratitis. Arch Ophthalmol. 1976 Aug;94(8):1387–1389. doi: 10.1001/archopht.1976.03910040255019. [DOI] [PubMed] [Google Scholar]
  36. Leibowitz H. M., Kupferman A. Periocular injection of corticosteroids: an experimental evaluation of its role in the treatment of corneal inflammation. Arch Ophthalmol. 1977 Feb;95(2):311–314. doi: 10.1001/archopht.1977.04450020112019. [DOI] [PubMed] [Google Scholar]
  37. Levine N. D., Aronson S. B. Orbital infusion of steroids in the rabbit. Arch Ophthalmol. 1970 May;83(5):599–607. doi: 10.1001/archopht.1970.00990030599015. [DOI] [PubMed] [Google Scholar]
  38. MCCARTNEY H. J., DRYSDALE I. O., GORNALL A. G., BASU P. K. AN AUTORADIOGRAPHIC STUDY OF THE PENETRATION OF SUBCONJUNCTIVALLY INJECTED HYDROCORTISONE INTO THE NORMAL AND INFLAMED RABBIT EYE. Invest Ophthalmol. 1965 Jun;4:297–302. [PubMed] [Google Scholar]
  39. Mahlberg K., Uusitalo R. J., Gebhardt B., Kaufman H. E. Prevention of experimental corneal allograft rejection in rabbits using cyclosporin-collagen shields. Graefes Arch Clin Exp Ophthalmol. 1991;229(1):69–74. doi: 10.1007/BF00172265. [DOI] [PubMed] [Google Scholar]
  40. McDonald T. O., Borgmann A. R., Roberts M. D., Fox L. G. Corneal wound healing. I. Inhibition of stromal healing by three dexamethasone derivatives. Invest Ophthalmol. 1970 Sep;9(9):703–709. [PubMed] [Google Scholar]
  41. McGhee C. N., Noble M. J., Watson D. G., Dutton G. N., Fern A. I., Healey T. M., Midgley J. M. Penetration of topically applied prednisolone sodium phosphate into human aqueous humour. Eye (Lond) 1989;3(Pt 4):463–467. doi: 10.1038/eye.1989.69. [DOI] [PubMed] [Google Scholar]
  42. McGhee C. N., Watson D. G., Midgley J. M., Noble M. J., Dutton G. N., Fern A. I. Penetration of synthetic corticosteroids into human aqueous humour. Eye (Lond) 1990;4(Pt 3):526–530. doi: 10.1038/eye.1990.70. [DOI] [PubMed] [Google Scholar]
  43. MdDonald T. O., Kasten K., Hervey R., Gregg S., Smith D., Robb C. A. Comparative toxicity of dexamethasone and its tertiary butyl acetate ester after topical ocular instillation in rabbits. Am J Ophthalmol. 1973 Jul;76(1):117–125. doi: 10.1016/0002-9394(73)90017-2. [DOI] [PubMed] [Google Scholar]
  44. Murdick P. W., Keates R. H., Donovan E. F., Wyman M., Short C. Ocular penetration studies. II. Topical administration of prednisolone. Arch Ophthalmol. 1966 Oct;76(4):602–603. doi: 10.1001/archopht.1966.03850010604023. [DOI] [PubMed] [Google Scholar]
  45. Poland D. E., Kaufman H. E. Clinical uses of collagen shields. J Cataract Refract Surg. 1988 Sep;14(5):489–491. doi: 10.1016/s0886-3350(88)80003-8. [DOI] [PubMed] [Google Scholar]
  46. Quigley H. A., Pollack I. P., Harbin T. S., Jr Pilocarpine ocuserts. Long-term clinical trials and selected pharmacodynamics. Arch Ophthalmol. 1975 Sep;93(9):771–775. doi: 10.1001/archopht.1975.01010020665001. [DOI] [PubMed] [Google Scholar]
  47. Raab E. L. Limitation of motility after periocular corticosteroid injection. Am J Ophthalmol. 1974 Dec;78(6):996–998. doi: 10.1016/0002-9394(74)90813-7. [DOI] [PubMed] [Google Scholar]
  48. Roberts S. M., Lavach J. D., Macy D. W., Severin G. A. Effect of ophthalmic prednisolone acetate on the canine adrenal gland and hepatic function. Am J Vet Res. 1984 Sep;45(9):1711–1714. [PubMed] [Google Scholar]
  49. Rosenblum C., Dengler R. E., Jr, Geoffroy R. F. Ocular absorption of dexamethasone phosphate disodium by the rabbit. Arch Ophthalmol. 1967 Feb;77(2):234–237. doi: 10.1001/archopht.1967.00980020236017. [DOI] [PubMed] [Google Scholar]
  50. Salminen L. Review: systemic absorption of topically applied ocular drugs in humans. J Ocul Pharmacol. 1990 Fall;6(3):243–249. doi: 10.1089/jop.1990.6.243. [DOI] [PubMed] [Google Scholar]
  51. Schaeffer H. E., Krohn D. L. Liposomes in topical drug delivery. Invest Ophthalmol Vis Sci. 1982 Feb;22(2):220–227. [PubMed] [Google Scholar]
  52. Schoenwald R. D., Boltralik J. J. A bioavailability comparison in rabbits of two steroids formulated as high-viscosity gels and reference aqueous preparations. Invest Ophthalmol Vis Sci. 1979 Jan;18(1):61–66. [PubMed] [Google Scholar]
  53. Schoenwald R. D., Stewart P. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. J Pharm Sci. 1980 Apr;69(4):391–394. doi: 10.1002/jps.2600690407. [DOI] [PubMed] [Google Scholar]
  54. Short C., Keates R. H., Donovan E. F., Wyman M., Murdick P. W. Ocular penetration studies. I. Topical administration of dexamethasone. Arch Ophthalmol. 1966 May;75(5):689–692. doi: 10.1001/archopht.1966.00970050691021. [DOI] [PubMed] [Google Scholar]
  55. Sieg J. W., Robinson J. R. Corneal absorption of fluorometholone in rabbits. A comparative evaluation of corneal drug transport characteristics in anesthetized and unanesthetized rabbits. Arch Ophthalmol. 1974 Sep;92(3):240–243. doi: 10.1001/archopht.1974.01010010248016. [DOI] [PubMed] [Google Scholar]
  56. Smolin G., Hall J. M., Okumoto M., Ohno S. High doses of subconjunctival corticosteroid and antibody-forming cells in the eye and draining lymph nodes. Arch Ophthalmol. 1977 Sep;95(9):1631–1633. doi: 10.1001/archopht.1977.04450090153014. [DOI] [PubMed] [Google Scholar]
  57. Srinivasan B. D., Kulkarni P. S. Polymorphonuclear leukocyte response. Inhibition following corneal epithelial denudation by steroidal and nonsteroidal anti-inflammatory agents. Arch Ophthalmol. 1981 Jun;99(6):1085–1089. doi: 10.1001/archopht.1981.03930011085020. [DOI] [PubMed] [Google Scholar]
  58. Sugar J., Chandler J. W. Experimental corneal wound strength. Arch Ophthalmol. 1974 Sep;92(3):248–249. doi: 10.1001/archopht.1974.01010010256018. [DOI] [PubMed] [Google Scholar]
  59. Unterman S. R., Rootman D. S., Hill J. M., Parelman J. J., Thompson H. W., Kaufman H. E. Collagen shield drug delivery: therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humor. J Cataract Refract Surg. 1988 Sep;14(5):500–504. doi: 10.1016/s0886-3350(88)80006-3. [DOI] [PubMed] [Google Scholar]
  60. WEIMAR V. L., LEOPOLD I. H. Intraocular penetration of local hydrocortisone and cortisone. AMA Arch Ophthalmol. 1954 Nov;52(5):769–773. doi: 10.1001/archopht.1954.00920050775013. [DOI] [PubMed] [Google Scholar]
  61. WINE N. A., GORNALL A. G., BASU P. K. THE OCULAR UPTAKE OF SUBCONJUNCTIVALLY INJECTED C14 HYDROCORTISONE. 1. TIME AND MAJOR ROUTE OF PENETRATION IN A NORMAL EYE. Am J Ophthalmol. 1964 Sep;58:362–366. doi: 10.1016/0002-9394(64)91214-0. [DOI] [PubMed] [Google Scholar]
  62. Waltman S. R., Kaufman H. E. Use of hydrophilic contact lenses to increase ocular penetration of topical drugs. Invest Ophthalmol. 1970 Apr;9(4):250–255. [PubMed] [Google Scholar]
  63. Watson D. G., McGhee C. N., Midgley J. M., Dutton G. N., Noble M. J. Penetration of topically applied betamethasone sodium phosphate into human aqueous humour. Eye (Lond) 1990;4(Pt 4):603–606. doi: 10.1038/eye.1990.84. [DOI] [PubMed] [Google Scholar]
  64. Watson D. G., Midgley J. M., McGhee C. N. The analysis of corticosteroid acetates by gas chromatography/negative ion chemical ionization mass spectrometry. Rapid Commun Mass Spectrom. 1989 Jan;3(1):8–10. doi: 10.1002/rcm.1290030105. [DOI] [PubMed] [Google Scholar]
  65. Watson D., Noble M. J., Dutton G. N., Midgley J. M., Healey T. M. Penetration of topically applied dexamethasone alcohol into human aqueous humor. Arch Ophthalmol. 1988 May;106(5):686–687. doi: 10.1001/archopht.1988.01060130748037. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES